|
Volumn 31, Issue 2, 2006, Pages 245-247
|
Pulse itraconazole 400 mg daily in the treatment of chromoblastomycosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ITRACONAZOLE;
ADULT;
AGED;
ARTICLE;
BLOOD DISEASE;
CHROMOMYCOSIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE DURATION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG PULSE THERAPY;
FEMALE;
FONSECAEA PEDROSOI;
FUNGUS CULTURE;
FUNGUS ISOLATION;
HISTOLOGY;
HUMAN;
MALE;
PREDICTION;
PRIORITY JOURNAL;
SQUAMOUS CELL CARCINOMA;
TISSUE CULTURE;
TREATMENT DURATION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
UNSPECIFIED SIDE EFFECT;
AGED;
ANTIFUNGAL AGENTS;
CHROMOBLASTOMYCOSIS;
FEMALE;
HUMANS;
ITRACONAZOLE;
MALE;
MIDDLE AGED;
MITOSPORIC FUNGI;
PROSPECTIVE STUDIES;
TREATMENT OUTCOME;
|
EID: 33645072747
PISSN: 03076938
EISSN: 13652230
Source Type: Journal
DOI: 10.1111/j.1365-2230.2005.02024.x Document Type: Article |
Times cited : (29)
|
References (10)
|